Biotech

All Articles

Biogen, UCB document period 3 lupus win after falling short earlier test

.Biogen and also UCB's bank on advancing right into stage 3 on the back of an unsuccessful research ...

Aptadir wishes new RNA preventions may turn around complicated cancers cells

.Italian biotech Aptadir Therapeutics has actually introduced along with the assurance that its own ...

Wave surfs DMD effectiveness to regulators' doors, delivering stockpile

.Wave Lifestyle Sciences has fulfilled its own goal in a Duchenne muscular dystrophy (DMD) research,...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, occup...

Achilles trickles cell treatment system, prepares for discharges after skipping 'commercial feasibility' objectives

.Achilles Rehabs has wrecked its tactic. The British biotech is stopping work on its own clinical-ph...

Aligos proclaims period 2 MASH succeed, lowering liver body fat approximately 46%

.Aligos Rehabs is actually trumpeting a midstage win in metabolic-dysfunction affiliated steatohepat...

Basilea ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job cultivating brand-new antifungals has gotten a significant increase fro...

Capricor sells Europe rights to late-stage DMD treatment for $35M

.Possessing actually gathered up the united state rights to Capricor Therapeutics' late-stage Duchen...

FDA scraps adcomm for Applied's rare disease drug

.After dismissing the choice date for Applied Therapies' metabolic ailment medication govorestat, th...

Novo inks $600M NanoVation package to research genetic drugs ex-liver

.Novo Nordisk is proceeding its press into hereditary medications, accepting to pay NanoVation Thera...